KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Gross Profit: 2015-2025

Historic Gross Profit for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $196.9 million.

  • Medpace Holdings' Gross Profit rose 16.53% to $196.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $733.6 million, marking a year-over-year increase of 19.33%. This contributed to the annual value of $656.3 million for FY2024, which is 25.13% up from last year.
  • According to the latest figures from Q3 2025, Medpace Holdings' Gross Profit is $196.9 million, which was up 9.40% from $180.0 million recorded in Q2 2025.
  • Over the past 5 years, Medpace Holdings' Gross Profit peaked at $196.9 million during Q3 2025, and registered a low of $74.7 million during Q2 2021.
  • In the last 3 years, Medpace Holdings' Gross Profit had a median value of $155.1 million in 2024 and averaged $157.8 million.
  • Data for Medpace Holdings' Gross Profit shows a peak YoY soared of 36.67% (in 2022) over the last 5 years.
  • Over the past 5 years, Medpace Holdings' Gross Profit (Quarterly) stood at $88.0 million in 2021, then soared by 31.54% to $115.7 million in 2022, then rose by 18.21% to $136.8 million in 2023, then skyrocketed by 30.34% to $178.3 million in 2024, then climbed by 16.53% to $196.9 million in 2025.
  • Its last three reported values are $196.9 million in Q3 2025, $180.0 million for Q2 2025, and $178.3 million during Q1 2025.